Displaying 222 results out of a total of 3930 publications.
Simultaneous targeting of EGFR, HER2 and HER4 by afatinib overcomes intrinsic and acquired cetuximab resistance in head and neck squamous cell carcinoma cell lines
De Pauw, I;Lardon, F;Van den Bossche, J;Baysal, H;Fransen, E;Deschoolmeester, V;Pauwels, P;Peeters, M;Vermorken, JB;Wouters, A;
Mol Oncol, Mol Oncol ():, 2018
View publication
Mol Oncol, Mol Oncol ():, 2018
Afatinib is a new therapeutic approach in chordoma with a unique ability to target EGFR and Brachyury
Magnaghi, P;Salom, B;Cozzi, L;Amboldi, N;Ballinari, D;Tamborini, E;Gasparri, F;Montagnoli, A;Raddrizzani, L;Somaschini, A;Bosotti, R;Orrenius, C;Bozzi, F;Pilotti, S;Galvani, A;Sommer, J;Stacchiotti, S;Isacchi, A;
Mol. Cancer Ther., Mol. Cancer Ther. ():, 2017
View publication
Mol. Cancer Ther., Mol. Cancer Ther. ():, 2017
In vitro study of the Polo-like kinase 1 inhibitor volasertib in non-small cell lung cancer reveals a role for the tumor suppressor p53
Van den Bossche, J;Deben, C;De Pauw, I;Lambrechts, H;Hermans, C;Deschoolmeester, V;Jacobs, J;Specenier, P;Pauwels, P;Vermorken, JB;Peeters, M;Lardon, F;Wouters, A;
Mol Oncol, Mol Oncol ():, 2019
View publication
Mol Oncol, Mol Oncol ():, 2019
Dendrimer-doxorubicin conjugates exhibit improved anticancer activity and reduce doxorubicin-induced cardiotoxicity in a murine hepatocellular carcinoma model
Kuruvilla, SP;Tiruchinapally, G;Crouch, AC;ElSayed, MEH;Greve, JM;
PLoS ONE, PLoS ONE 12(8):e0181944, 2017
View publication
PLoS ONE, PLoS ONE 12(8):e0181944, 2017
A versatile drug delivery system targeting senescent cells
Muoz-Espn, D;Rovira, M;Galiana, I;Gimnez, C;Lozano-Torres, B;Paez-Ribes, M;Llanos, S;Chaib, S;Muoz-Martn, M;Ucero, AC;Garaulet, G;Mulero, F;Dann, SG;VanArsdale, T;Shields, DJ;Bernardos, A;Murgua, JR;Martnez-Mez, R;Serrano, M;
EMBO Mol Med, EMBO Mol Med ():, 2018
View publication
EMBO Mol Med, EMBO Mol Med ():, 2018
Repression of Stress-Induced LINE-1 Expression Protects Cancer Cell Subpopulations from Lethal Drug Exposure
Guler, GD;Tindell, CA;Pitti, R;Wilson, C;Nichols, K;KaiWai Cheung, T;Kim, HJ;Wongchenko, M;Yan, Y;Haley, B;Cuellar, T;Webster, J;Alag, N;Hegde, G;Jackson, E;Nance, TL;Giresi, PG;Chen, KB;Liu, J;Jhunjhunwala, S;Settleman, J;Stephan, JP;Arnott, D;Classon, M;
Cancer Cell, Cancer Cell 32(2):221-237.e13, 2017
View publication
Cancer Cell, Cancer Cell 32(2):221-237.e13, 2017
Effect of Lead on Human Middle Ear Epithelial Cells
Kim, SH;Shin, SH;Go, YY;Chae, SW;Song, JJ;
Biomed Res Int, Biomed Res Int 2018():5058729, 2018
View publication
Biomed Res Int, Biomed Res Int 2018():5058729, 2018
Amplification of wild type KRAS imparts resistance to crizotinib in MET exon 14 mutant non-small cell lung cancer
Bahcall, M;Awad, MM;Sholl, LM;Wilson, FH;Xu, M;Wang, S;Palakurthi, S;Choi, J;Ivanova, E;Leonardi, GC;Ulrich, BC;Paweletz, CP;Kirschmeier, PT;Watanabe, M;Baba, H;Nishino, M;Nagy, RJ;Lanman, RB;Capelletti, M;Chambers, ES;Redig, AJ;VanderLaan, PA;Costa, DB;Imamura, Y;Janne, PA;
Clin. Cancer Res., Clin. Cancer Res. ():, 2018
View publication
Clin. Cancer Res., Clin. Cancer Res. ():, 2018
MDM2 Integrates Cellular Respiration and Apoptotic Signaling through NDUFS1 and the Mitochondrial Network
Elkholi, R;Abraham-Enachescu, I;Trotta, AP;Rubio-Patio, C;Mohammed, JN;Luna-Vargas, MPA;Gelles, JD;Kaminetsky, JR;Serasinghe, MN;Zou, C;Ali, S;McStay, GP;Pfleger, CM;Chipuk, JE;
Mol. Cell, Mol. Cell ():, 2019
View publication
Mol. Cell, Mol. Cell ():, 2019
Targeting AR Variant-coactivator Interactions to Exploit Prostate Cancer Vulnerabilities
Magani, F;Peacock, SO;Rice, MA;Martinez, MJ;Greene, AM;Magani, PS;Lyles, R;Weitz, JR;Burnstein, KL;
Mol. Cancer Res., Mol. Cancer Res. ():, 2017
View publication
Mol. Cancer Res., Mol. Cancer Res. ():, 2017